Graciela E Moya

High prevalence of CYP2D6 ultrarapid metabolizers in a mestizo Colombian population in relation to Hispanic mestizo populations.

R. Barrantes, E. Tarazona-Santos, A. Llerena, 2020, Pharmacogenomics.

The genomic landscape of balanced cytogenetic abnormalities associated with human congenital anomalies

Edwin Cuppen, Claire Redin, Ryan L. Collins, 2016, Nature Genetics.

Challenges and Opportunities for Clinical Pharmacogenetic Research Studies in Resource-Limited Settings: Conclusions From the Council for International Organizations of Medical Sciences-Ibero-American Network of Pharmacogenetics and Pharmacogenomics Meeting.

E. Tarazona-Santos, A. Llerena, E. Terán, 2020, Clinical therapeutics.

Population pharmacogenetics of Ibero-Latinoamerican populations (MESTIFAR 2014).

E. Tarazona-Santos, A. Llerena, E. Terán, 2015, Pharmacogenomics.

Genomic Ancestry, CYP2D6, CYP2C9, and CYP2C19 Among Latin Americans

R. Barrantes, E. Tarazona-Santos, A. Llerena, 2019, Clinical pharmacology and therapeutics.

Pharmacogenetics and ethnicity: relevance for clinical implementation, clinical trials, pharmacovigilance and drug regulation in Latin America.

E. Tarazona-Santos, A. Llerena, E. Terán, 2016, Pharmacogenomics.

Interethnic Variability in CYP2D6, CYP2C9, and CYP2C19 Genes and Predicted Drug Metabolism Phenotypes Among 6060 Ibero- and Native Americans: RIBEF-CEIBA Consortium Report on Population Pharmacogenomics.

R. Barrantes, E. Tarazona-Santos, A. Llerena, 2018, Omics : a journal of integrative biology.